NTBL
Notable Labs Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$2.39M
P/E Ratio
—
EPS
$-1.09
Beta
—
52W High
$0.00
52W Low
$0.00
50-Day MA
$0.41
200-Day MA
$0.87
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Notable Labs Inc.
Notable Labs, Inc. is a clinical-stage platform therapeutic company that develops predictive precision medicine for cancer patients. The company is headquartered in Foster City, California.
Fundamentals
| Revenue (TTM) | 313,000 |
| Gross Profit (TTM) | 8,000 |
| EBITDA | $-15.12M |
| Operating Margin | -269000.00% |
| Return on Equity | -464.30% |
| Return on Assets | -106.10% |
| Revenue/Share (TTM) | $0.04 |
| Book Value | $0.74 |
| Price-to-Book | 0.03 |
| Price-to-Sales (TTM) | 7.65 |
| EV/Revenue | 7.41 |
| EV/EBITDA | -0.83 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $9.66M |
| Float | $2.07M |
| % Insiders | 32.95% |
| % Institutions | 4.55% |
More HEALTHCARE Stocks
Data last updated: 5/2/2026